Kang, H.; Lee, J.B.; Khatri, I.; Na, Y.; D’Souza, C.; Arruda, A.; Minden, M.D.; Zhang, L.
Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib. Cancers 2021, 13, 5039.
https://doi.org/10.3390/cancers13205039
AMA Style
Kang H, Lee JB, Khatri I, Na Y, D’Souza C, Arruda A, Minden MD, Zhang L.
Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib. Cancers. 2021; 13(20):5039.
https://doi.org/10.3390/cancers13205039
Chicago/Turabian Style
Kang, Hyeonjeong, Jong Bok Lee, Ismat Khatri, Yoosu Na, Cheryl D’Souza, Andrea Arruda, Mark D. Minden, and Li Zhang.
2021. "Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib" Cancers 13, no. 20: 5039.
https://doi.org/10.3390/cancers13205039
APA Style
Kang, H., Lee, J. B., Khatri, I., Na, Y., D’Souza, C., Arruda, A., Minden, M. D., & Zhang, L.
(2021). Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib. Cancers, 13(20), 5039.
https://doi.org/10.3390/cancers13205039